A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer
Clinical trial NCT01326000 · COMPLETED
Trial details
- NCT number
- NCT01326000
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2013-12-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.